NCT06234501Recruiting

Testing the Efficacy of 100mg Vitamin-B6 Daily for Sensory Reactivity in Autism

Testing the Potential of High-dose Vitamin B6 Supplements for Sensory Reactivity in Autism

Source: ClinicalTrials.gov · Last updated 7 Oct 2026

Brief summary (registry, in English)

This clinical trial aims to explore the effect of Vitamin B6 supplementation on anxiety sensory hyperreactivity in autistic adults. Researchers will compare a placebo group to high-dose Vitamin-B6 to see if vitamin B6 reduce anxiety and sensory reactivity differences in autism.

Status (registry): Recruiting
Study type: Interventional
Enrollment: 40 (estimated)
First submitted: 22 Jan 2024
Start date: 8 Nov 2024
Primary completion date: 13 Nov 2026
Lead sponsor: University of Reading
Diseases: Autism
NCT number: NCT06234501

What you commit to

Study type: Interventional
Planned participants: 40
From 8 Nov 2024 to the primary completion date, 13 Nov 2026
1 site in 1 country
Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

Taking any supplement that contains more than 2mg of Vitamin B6 or taking GABA agonist drugs

Other illness

Have a medical history of peripheral neuropathy

Other

lactose intolerance (placebo tablet is lactose based)

Who the study is looking for

Between the ages of 18 to 60
With a diagnosis of autism

Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

Site	City	Country	Site status
University of Reading Coordinator of this site? Confirm its status	Reading	United Kingdom	Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.